Surgery in Practice and Science (Dec 2023)

Residential Distance to the Cancer Center and Outcomes after Robotic-Assisted Pulmonary Lobectomy

  • Allison O. Dumitriu Carcoana,
  • Jenna C. Marek,
  • William J. West, III,
  • Cole R. Fiedler,
  • William N. Doyle, Jr.,
  • Kristie M. Labib,
  • Lauren C. Ladehoff,
  • Jose A. Malavet,
  • Gregory Fishberger,
  • Carla C. Moodie,
  • Joseph R. Garrett,
  • Jenna R. Tew,
  • Jobelle J.A.R. Baldonado,
  • Jacques P. Fontaine,
  • Eric M. Toloza

Journal volume & issue
Vol. 15
p. 100210

Abstract

Read online

ABSTRACT: Background: Outcomes of lung cancer patients traveling greater distances for surgical oncology care are not well-described. We investigated the effects of increased travel burden after robotic-assisted pulmonary lobectomy (RAPL) for lung cancer. Methods: Clinical characteristics and surgical outcomes of 711 consecutive patients who underwent RAPL from September 2010 to March 2022 were compared, stratified by primary residential ZIP code <160 km or ≥160 km from the cancer center. Results: Of 711 study patients, 515 (72.4%) lived within 160 km and 196 (27.6%) lived ≥160 km away. There were no differences in Charlson Comorbidity Index scores or tumor characteristics. Those traveling ≥160 km experienced more unfavorable perioperative outcomes and postoperative complications, and had worse median survival time by 1.68 years, but this survival difference did not reach statistical significance. Conclusions: With the growing centralization of cancer care, travel burden may emerge as a predictor of surgical oncology outcomes.

Keywords